Approval · Notice of Compliance 24265 · 2020
SAPHRIS: Notice of Compliance 24265
Issued September 18, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24265
- Date
- September 18, 2020
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Reaponse to advisement letter to revise warnings and precautions section of the product monograph